Stock vs Stock Comparison

Agilent Technologies, Inc. vs Abbott Laboratories

A and ABT are evenly matched across key metrics.

A$135.05
ABT$86.97

🏆 Tale of the Tape

44
AABT
18.8%Profitability (Net Margin)14.7%
27.3xValuation (P/E)24.0x
11.8%Efficiency (ROIC)10.1%
5/9Health (Piotroski F)5/9
4.6Safety (Altman Z)4.9
6.7%Growth (Rev YoY)5.7%
0.32Risk (Sharpe 1Y)-1.05
0.89xBalance Sheet (D/E)0.64x
3.41%FCF Yield4.21%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.200
252-Day Correlation
0.306
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricAABT
Market Cap$38.2B$149.1B
P/E Ratio27.3x24.0x
Forward P/E20.5x14.1x
P/B5.37x2.86x
Dividend Yield0.75%2.94%
Beta1.220.65

Quantitative Metrics

MetricAABT
DCF Fair Value$50.34$57.20
DCF Upside-57.1%-43.2%
Piotroski F5/95/9
Altman Z4.574.87
Beneish M-2.46-2.53
FCF Yield3.41%4.21%
Net Debt/EBITDA0.7x0.1x
ROIC11.8%10.1%
WACC12.1%9.4%
ROIC – WACC-0.3pp0.7pp
Gross Margin52.4%56.4%
Net Margin18.8%14.7%
Rev Growth YoY6.7%5.7%
Sharpe (1Y)0.32-1.05
Max Drawdown 3Y
FCF Payout Ratio24%56%

A Price

Loading chart...

ABT Price

Loading chart...

ETF Exposure

A found in:

MOAT1.31%
VOT0.77%
XLV0.61%
VHT0.53%
VO0.33%
ONEV0.29%
RSP0.18%
VIG0.15%
VTV0.13%
SCHV0.12%
SPYV0.11%
IWD0.11%
VONV0.10%
ONEO0.09%
ESGV0.07%
QUS0.07%
SPLG0.07%
IVV0.07%
ITOT0.06%
SCHX0.06%
SCHB0.05%
SPY0.05%
VTI0.05%
VOO0.05%
VONE0.05%
SPTM0.05%
URTH0.04%
ACWI0.04%
DGRW0.04%

ABT found in:

IHI16.06%
IYH2.88%
XLV2.85%
VHT2.55%
DGRW1.71%
XHE1.36%
NOBL1.34%
SDY0.99%
MGV0.78%
VIG0.71%
VFMV0.69%
SCHV0.68%
VYM0.65%
VTV0.61%
IWD0.58%
QUS0.57%
SPYV0.53%
VONV0.48%
IVV0.37%
SPLG0.37%
ESGV0.36%
ITOT0.33%
SCHX0.33%
SCHB0.30%
VOO0.26%
VONE0.24%
SPY0.24%
URTH0.24%
VTI0.23%
SPTM0.22%
ACWI0.20%
RSP0.17%
VT0.14%
ONEO0.08%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

A vs ABT: Head-to-Head Analysis

Agilent Technologies, Inc. (A) and Abbott Laboratories (ABT) represent two companies in the Healthcare sector. Our quantitative Tale of the Tape shows these companies are evenly matched across profitability, valuation, and risk metrics.

In terms of capital efficiency, A generates a return on invested capital (ROIC) of 11.8% compared to ABT's 10.1%. This suggests A is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between A and ABT is 0.200, indicating low correlation, making them an effective diversification pair in a portfolio context.

A appears in 29 ETFs tracked by SecuritiesDB, while ABT appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, A or ABT?

Our quantitative analysis compares A and ABT across nine fundamental dimensions. A and ABT are evenly matched across key metrics. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are A and ABT correlated?

The 252-day correlation between A and ABT is 0.200. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.